Author:
Ahmed Zunaid,Deyama Yoshiaki,Yoshimura Yoshitaka,Suzuki Kuniaki
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference44 articles.
1. Jamieson ER, Lippard SJ (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99:2451–2466
2. Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307–320
3. Safaei R, Katano K, Samimi G, Holzer AK, Naerdemann W, Howell SB (2004) Contribution of endocytic pathways to the uptake of cisplatin in sensitive and resistant ovarian cancer cells. Proc Am Assoc Cancer Res 45:120
4. Katano K, Kondo A, Safaei R, Holzer AK, Samimi G, Mishima M et al (2002) Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res 62:6559–6565
5. Safaei R, Katano K, Samimi G, Naerdemann W, Stevenson JL, Rochdi M et al (2004) Cross-resistance to cisplatin in cells with acquired resistance to copper. Cancer Chemother Pharmacol 53:239–246